Biologics Contract Development and Manufacturing Organization (CDMO) Market Size to Grow by US $32.89 billion by 2031

The global biologics contract development and manufacturing organization (CDMO) market was valued at USD 12.54 billion in 2022. It is estimated to reach USD 32.89 billion by 2031, growing at a CAGR of 11.31% during the forecast period (2023&ndash;203 Report Scope:<table><tr><td>Report Metric</td><td>Details</td></tr><tr><td><strong>Study Period</strong></td><td>2019-2031</td></tr><tr><td><strong>Historical Period</strong></td><td>2019-2021</td></tr><tr><td><strong>Forecast Period</strong></td><td>2023-2031</td></tr><tr><td><strong>Base Year</strong></td><td>2022</td></tr><tr><td><strong>Base Year Market Size</strong></td><td>USD 12.54 Billion</td></tr><tr><td><strong>Forecast Year</strong></td><td>2031</td></tr><tr><td><strong>Forecast Year Market Size</strong></td><td>USD 32.89 Billion</td></tr><tr><td><strong>Forecast Year CAGR</strong></td><td>11.31%</td></tr> <tr><td><strong>Largest Market</strong></td><td>North America</td></tr><tr><td><strong>Fastest Growing Market</strong></td><td>Europe</td></tr> </table>

全球生物制药合同研发与生产组织（CDMO）市场在2022年达到了价值125.4亿美元。预计到2031年，该市场规模将增长至328.9亿美元，在预测期内（2023-2031年）的复合年增长率将达到11.31%。本报告的范围如下：<table><tr><td>报告指标</td><td>详细信息</td></tr><tr><td><strong>研究期间</strong></td><td>2019-2031</td></tr><tr><td><strong>历史期间</strong></td><td>2019-2021</td></tr><tr><td><strong>预测期间</strong></td><td>2023-2031</td></tr><tr><td><strong>基准年份</strong></td><td>2022</td></tr><tr><td><strong>基准年份市场规模</strong></td><td>125.4亿美元</td></tr><tr><td><strong>预测年份</strong></td><td>2031</td></tr><tr><td><strong>预测年份市场规模</strong></td><td>328.9亿美元</td></tr><tr><td><strong>预测年份CAGR</strong></td><td>11.31%</td></tr><tr><td><strong>最大市场</strong></td><td>北美</td></tr><tr><td><strong>增长最快的市场</strong></td><td>欧洲</td></tr></table>